Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 555,199 |
|
|||||
| News | - | ||||||
| Day High | 7.28 | Low High |
|||||
| Day Low | 6.67 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Fulcrum Therapeutics Inc | FULC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.22 | -3.12% | 6.84 | 18:11:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.00 | 6.67 | 7.28 | 6.84 | 7.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,428 | 555,199 | $ 6.89 | $ 3,827,192 | - | 2.43 - 13.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:04:23 | 75 | $ 6.53 | USD |
Fulcrum Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 423.64M | 61.94M | - | 2.81M | -97.34M | -1.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fulcrum Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FULC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.81 | 7.81 | 6.67 | 7.29 | 446,674 | -0.97 | -12.42% |
| 1 Month | 9.76 | 10.09 | 6.67 | 8.63 | 559,219 | -2.92 | -29.92% |
| 3 Months | 7.04 | 13.70 | 6.67 | 9.58 | 645,435 | -0.20 | -2.84% |
| 6 Months | 3.66 | 13.70 | 3.14 | 7.47 | 620,987 | 3.18 | 86.89% |
| 1 Year | 2.45 | 13.70 | 2.43 | 5.51 | 1,019,079 | 4.39 | 179.18% |
| 3 Years | 11.47 | 33.0975 | 2.25 | 11.39 | 996,840 | -4.63 | -40.37% |
| 5 Years | 14.50 | 33.0975 | 2.25 | 11.42 | 671,294 | -7.66 | -52.83% |
Fulcrum Therapeutics Description
| Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability. |
